Lenalidomide in patients with refractory or multiple relapsed Hodgkin lymphoma.
Boris
B
Böll
Peter
P
Borchmann
Max S
MS
Topp
Mathias
M
Hänel
Katrin S
KS
Reiners
Andreas
A
Engert
Ralph
R
Naumann
D000328:Adult; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D005260:Female; D006689:Hodgkin Disease / Q000188:drug therapy*; D006801:Humans; D000077269:Lenalidomide; D008297:Male; D008875:Middle Aged; D009367:Neoplasm Staging; D012008:Recurrence; D013792:Thalidomide / Q000031:analogs & derivatives* / Q000627:therapeutic use; D016896:Treatment Outcome; D055815:Young Adult
D000970:Antineoplastic Agents; D013792:Thalidomide; D000077269:Lenalidomide